Terapia Con Estrogeni Del Tumore Prostatico: Certezze O Dubbi?

Huggins C. , Hodges C. V. : Studies on prostatic cancer. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1; 293 (1941).

Alder A. : Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy. Brit. Med. J., 1; 28 (1968).

Leinonen P. , Hammond G. L. , Lukkarinen O. , Vihko R. : Serum sex hormone binding globuline and testosterone binding after estradiol administration, castration and their combination in men with prostatic carcinoma. Invest, Urol., 17; 24 (1979).

Yanaihara T. , Troen P. , Troen B. R. , Troen M. L. : Studies of the human testis. III: Effect of estrogen on testosterone formation in human testis in vitro. J. Clin. Endocrinol. Metab., 34; 968 (1972).

Shimazaki J. , Horaguchi T. , Ohki Y. , Shida K. : Properties of testosterone 5-alfa-reductase of purified nuclear fraction from ventral prostate of rats. Endocrinol. Jap., 18; 187 (1971).

Harper M. E. , Fahmy A. R. , Pierrepoint C. G. , Griffiths K. : The effect of some stilbestrol compounds on DNA polymerase from human prostatic tissue. Steroids, 15; 89 (1970).

Di Silverio F. , Tenaglia R. , Concolino G. , Sciarra F. : Significato prognostico dei livelli plasmatici tissutali degli ormoni androgeni nel carcinoma prostatico. Atti S.I.U., 55° Congr., p. 14. Catania 1982.

Lasio E. , Coppi F. : Correlazione fra sistema endocrino e apparato urogenitale. Atti S.I.U., 44° Congr., p. 1. Venezia 1971.

Blackard C. E. : The Veterans Administration Cooperative Urological Research Group's studies of carcinoma of prostate: a review. Cancer Chemoth. Rep., 59; 225 (1975).

Maatman T. J. , Gupta M. K. , Montie J. E. : Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate. J. Urol., 133; 620 (1985).

The Veterans Admniistration Cooperative Urological Research Group: Treatment and survival of patients with cancer of the prostate. Surg., Gynec. & Obst., 124; 1011 (1967).

Byar D. P. : The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate. Cancer, 32; 1126 (1973).

Rob'nron M. R. G. , Thomas B. G. : Effect of hormonal therapy on plasma testosterono levels in prostatic carcinoma. Brit. Med. J., 4; 391 (1971).

Seller J. , Albert J. D. : Comparision of various hormonal therapies for prostatic carcinoma. Sem. in Oncol., 10; Suppl. 4, 34 (1983).

Shearer R. J. , Hendry W. F. , Sommerville I. F. , Fergusson J. D. : Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. Brit. J. Urol., 45; 668 (1973).

De Voogt H. T. , Smith P. H. , Pavone Macaluso M. , De Pauw M. , Suciu S. (Members of the European Organization for Research on Treatment for Cancer Urological Group): Cardiovascular side effects of diethylstilbelstrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer, trials 30761 and 30762. J. Urol., 135; 303 (1986).

Pollen J. J. : Endocrine treatment of prostatic cancer. Urology, 21; 555 (1983).

Glashan R. W. , Robinson M. R. G. : Cardiovascular complication in the treatment of prostatic carcinoma. Brit. J. Urol., 53; 624 (1981).

Henriksson P. , Edhag O. : Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. Brit. Med. J., 293; 413 (1986).

Hedlund J. : World Healt Organization Conference Prostatic Cancer. Stockholm 1979.

Citrin D. L. , Kies M.S. , Wallermark C.B. , Khandekar J. , Kaplan E. , Camacho F. , Lind R. : A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostatic cancer. Cancer, 56; 457 (1986).

Nesbit R. M. , Baum W. C. : Endocrine control of prostatic carcinoma, clinical and statistical survey of 1818 cases. J.A.M.A., 143; 1317 (1950).

Emmett J. L. , Greene L. F. , Papantoniou A. : Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies. J. Urol., 83; 417 (1960).

Smith P. H. , Suciu S. , Robinson M. R. G. , Richards B. , Bastable J. R. G. , Glashan R. W. , Bouffioux C. , Lardennois B. , Williams R. E. , De Panco M. , Sylvester R. : A comparision of the effect of diethylstilbestrol with low-dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer. J. Urol., 136; 619 (1986).

Anderson L. , Berlin T. : Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study. Scand. J. Urol Nephrol., 55; Suppl., 143 (1980).

Benson R. C. Jr. : Estramustine phosphate as primary therapy for metastatic prostate cancer: preliminary results of the University of Wisconsin trial. Urology, 23; 69 (1984).

The Leuprolide Study Group: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N. Engl. J. Med., 311; 12181 (1984).

Labrie F. , Dupont A. , Belanger A. : New approach in the treatment of prostatic cancer: complete instead of only partial withdrawl of androgens. Prostate, 4; 579 (1983).

Stone A. R. , Hargreave T. B. , Chisholm G. D. : The diagnosis of oestrogen escape and the role of secondary orchiectomy in prostatic cancer. Brit. J. Urol., 52; 535 (1980).

Biorn G. L. , Gray C. P. , Strauss E. : Orchiectomy after presumed oestrogen failure in treatment of carcinoma of the prostate. West J. Med., 130; 363 (1979).

Chisholm G. D. , O'Donoghue E. P. N. , Kennedy C. L. : The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate. Brit. J. Urol., 49; 717 (1977).